UTHR

United Therapeutics Corporation (UTHR)

Last Price$365.0(0.4%)
Market Cap$16.2B
LTM Operating Income
$1,279.4M
YoY Growth
+16.3%
3Y CAGR
+41.5%
5Y CAGR
N/A
Stock quality & Intrinsic value
8/10
15.5% undervalued

United Therapeutics Corporation Operating Income

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Operating Income
$13.2M
$42.9M
$29.0M
$6,303.0K
($82.1M)
$26.0M
$164.0M
$317.8M
$421.6M
$292.5M
$538.8M
$699.0M
$1,061.7M
$814.9M
$805.4M
($187.6M)
$593.6M
$555.9M
$979.7M
$1,184.9M
UTHR
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for UTHR and see if it's the right time to invest.
Dive in

United Therapeutics Corporation (UTHR) Operating Income comparison analysis

Crunching data... Almost there!

UTHR key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is United Therapeutics Corporation's Operating Income?

As of today, United Therapeutics Corporation's last 12-month Operating Income is $1,279.4M, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is United Therapeutics Corporation's Operating Income growth rate?

Over the last year, United Therapeutics Corporation's Operating Income growth was 16.3%. The average annual Operating Income growth rates for United Therapeutics Corporation have been 52.3% over the past three years, N/A over the past five years.

3) Is United Therapeutics Corporation's Operating Income growth rate Good?

Over the last year, United Therapeutics Corporation's Operating Income growth was 16.3%, which is higher than industry growth of (0.1%). It indicates that United Therapeutics Corporation's Operating Income growth is Good.